Bombesin (BN) interacts with two mammalian receptor subtypes termed gastrin-releasing peptide (GRP)-preferring (GRP-R) and neuromedin B (NMB)-preferring (NMB-R) that may mediate the satiety action of BN. We examined the feeding behavior of mice that were deficient in the GRP-R (GRP-R KO) to assess the overall contribution of this receptor subtype in the feeding actions of BN-related peptides. GRP-R KO mice failed to suppress glucose intake in response to systemically administered BN and GRP 18-27 , whereas both peptides elicited a potent reduction of intake in wild-type (WT) mice. Neither GRP-R KO nor WT mice suppressed glucose intake following NMB administration. Unlike the impaired responses to BN-like peptides, the feeding inhibitory action of cholecystokinin was enhanced in GRP-R KO mice. Consistent with behavioral results, GRP-R KO mice also exhibited a reduction in c-Fos immunoreactivity in the nucleus of the solitary tract (NTS) and paraventricular nucleus (PVN) following peripheral administration of BN. An evaluation of meal patterns showed that GRP-R KO mice ate significantly more at each meal than WT mice, although total 24 h food consumption was equivalent. A long-term analysis of body weight revealed a significant elevation in GRP-R KO mice compared with WT littermates beginning at 45 weeks of age. These data suggest that the GRP-R mediates the feeding effects of BN-like peptides and participates in the termination of meals in mice.
Introduction
Bombesin, a tetradecapeptide originally isolated from amphibian skin (Anastasi et al. 1971) , represents a large family of structurally related peptides with a wide array of physiological and behavioral effects in mammals (reviewed in Lebacq-Verheyden et al. 1990 ). Gastrin-releasing peptide (GRP) and neuromedin B (NMB) are two mammalian peptides that share close structural homology with BN and are widely distributed in the gastrointestinal tract and brain. To date, three mammalian BN receptor subtypes have been detected by molecular cloning techniques. These include the GRP-preferring receptor (GRP-R) (Spindel et al. 1990 , Battey et al. 1991 , NMB-preferring receptor (NMB-R) (Wada et al. 1991) and bombesin receptor subtype 3 (BRS-3) (Gorbulev et al. 1992 , Fathi et al. 1993 . Although BRS-3 shares approximately 50% of its amino acid sequence with GRP and NMB it does not interact with natural agonists that have high affinity for other BN-like peptide receptors and, at present, no endogenous ligand for BRS-3 has been identified .
Exogenous administration of BN, GRP and NMB suppresses food intake in a number of mammalian species, including humans (reviewed in Merali et al. 1999) . BN binds with equal and high affinity to both NMB-R and GRP-R (von Schrenk et al. 1989 ) and activation of either or both receptor subtypes could produce feeding suppression. Studies in rats using selective agonists and antagonists to investigate the role of BN receptor subtypes in food intake have yielded conflicting results. For example, complete dose-response analyses comparing the feeding suppression produced by peripheral administration of BN, GRP and NMB suggested the likelihood that BN's effects on food intake were mediated by both GRP and NMB receptors (Ladenheim et al. 1996b ). However, experiments using highly selective antagonists for GRP-R have shown a complete blockade of BN-induced satiety, supporting the view that only the GRP-R is involved in BN's feeding effects (Kirkham et al. 1994 ).
An alternative means of evaluating the role of a specific BN receptor subtype in feeding suppression by BN-like peptides is through use of an animal model in which one of the receptor subtypes is deleted. The development of a mouse that is deficient in the GRP-R (Wada et al. 1997 , Hampton et al. 1998 provides the opportunity to examine the relative contribution of GRP and NMB receptor subtypes to feeding suppression produced by BN-like peptides, as well as the role of this receptor subtype in normal feeding behavior.
In the present set of experiments we used this animal model to conduct a complete dose-response analysis for feeding suppression produced by peripheral administration of BN, GRP and NMB. We also compared central neuronal activation elicited by these peptides in GRP-R knockout (GRP-R KO) and wild-type (WT) mice using c-Fos immunohistochemistry. In addition, we examined suppression of food intake produced by cholecystokinin (CCK), a brain-gut peptide that potently reduces food intake but is not related to BN. To determine if deletion of GRP-R affects normal feeding and body weight in mice we performed a short-term analysis of meal patterns and long-term measurements of body weight. Verification of GRP-R deletion was evaluated by in vitro receptor autoradiography.
Materials and Methods

Behavioral testing with peptides
Adult male GRP-R KO mice and WT mice with a starting weight of 28-36 g were the experimental subjects. The generation of these mice is described in detail in a previous publication (Hampton et al. 1998) . Mice were housed individually in plastic cages in a temperaturecontrolled room on a 12:12 h light dark cycle. Food and water were always available except during behavioral testing. All testing was done at 1400 h in individual 8x8 inch Plexiglas chambers during the light phase of the light dark cycle.
Mice were habituated to the experimental protocol prior to testing with peptides. Each mouse was removed from its home cage and injected i.p. with 0·9% saline. They were then placed in the Plexiglas test chamber with a 0·5 kcal/ml glucose solution freely available for 30 min.
When consistent glucose intake was established (5 trials) mice were then tested for their feeding response to peptides. They were administered an i.p. injection of vehicle (0·9% bacteriostatic saline) or BN (1, 3·2, 10 and 32 nmol/kg), GRP 18-27 (10, 32, 100 and 320 nmol/kg) and NMB (32, 100 and 320 nmol/kg). In addition, the response to cholecystokinin (CCK), a non BN-related peptide that is known to reliably suppress food intake, was examined at doses of 0·32, 1, 3·2 and 10 nmol/kg. Immediately following the injection, mice were given access to 0·5 kcal/ml glucose and the volume consumed was recorded 15 and 30 min later. All peptides were given in a volume of 1 ml/100 g body weight. Doses of peptides were administered in a counter-balanced design in randomized order. Doses of peptide were administered at least 48 h apart and preceded by a day in which saline was administered. All doses of one peptide were completed before testing the next peptide. The order for testing was BN, GRP, NMB and CCK.
Glucose intake after i.p. saline injection was averaged across test days to attain baseline intake for each peptide. Data for all peptides were analyzed separately for each group and at each time point using repeated measures ANOVA followed by planned t comparisons. For CCK, between-group comparisons were also performed.
Meal pattern analysis
To evaluate normal feeding behavior in GRP-R KO and WT mice, an analysis of meal patterns was conducted. Mice (n=5 per group) were placed in a feeding apparatus consisting of individual stations with a running wheel connected to a nest box constructed of black opaque Plexiglas (15 25 15 cm) and an opening for food access. The food bin was equipped with an infrared emitter and a detector that indicated when a 45 mg pellet (Bioserv rodent grain-based diet) was in the feeder. Pellets were delivered via a pellet dispenser attached to the outside of the feeding apparatus. Tap water was available at all times. Feeding stations were housed in a temperaturecontrolled room on a 12:12 h light dark cycle.
Feeding stations were connected to a computer interface which recorded the number of pellets removed from the feeding bin at 5 min intervals using CONMAN (Contingency Management) software (Spyder Systems, Bloomington, IN, USA). Meal criteria were set for greater than one pellet, followed by 10 min with no feeding. Because we were only interested in food intake, the running wheel was in a locked position for this experiment.
Prior to data collection, GRP-R KO and WT mice were acclimated to the feeding apparatus for at least 4 days to assure that they reliably took pellets from the feeding bin and produced minimal spillage. Twenty-four hour measurements for total grams of food consumed, meal number, pellet number and meal size were collected. Data for each measurement were analyzed using Student's unpaired t-test (one-tailed).
c-Fos immunohistochemistry
Tissue was collected for the determination of brain c-Fos activation induced by i.p. injection of BN in GRP-R KO (n=8, 44·7 3·2 g) and WT mice (n=7, 40 2·3 g). For this experiment, four GRP-R KO and two WT mice that had undergone the behavioral testing described above were used. Additional GRP-R KO mice (n=4) and WT mice (n=5) that were not involved in this experiment were added later to increase the number of animals for evaluation. Mice were deprived of food for 6 h before being injected i.p. with either saline or 32 nmol/kg BN.
Seventy-five minutes later, mice were anesthetized with Euthasol (pentobarbital sodium and phenytoin, Delmarva Laboratories), and perfused transcardially with 25 ml 0·1 M phosphate-buffered saline (PBS, pH 7·4) followed by 25 ml 4% paraformaldehyde in PBS. The fixed brains were removed and cryoprotected in 25% sucrose in PBS (w/v). Brains were cut on a cryostat at a thickness of 30 µm and tissue sections were collected in PBS.
Prior to the immunohistochemical procedure, the sections were incubated in 0·3% hydrogen peroxide for 60 min, thoroughly washed in PBS and pre-absorbed with normal goat serum in 0·1 M PBS containing 0·1% Triton X-100. They were then incubated for 48 h at 4 C in rabbit anti-c-Fos antiserum (Oncogene Science,1:30 000) followed by incubation in biotinylated goat anti-rabbit IgG and avidin-biotin-peroxidase complex (Elite Vectastain Kit, Vector Labs, Burlingame, CA, USA). The reaction product was visualized using nickel sulfate enhanced diaminobenzine (DAB) as the chromagen. Sections were mounted onto gelatin-coated slides, dehydrated in an ascending series of alcohols and coverslipped.
For quantification of c-Fos immunoreactivity, images from the area postrema (AP), nucleus of the solitary tract (NTS) and paraventricular nucleus of the hypothalamus (PVN) in WT and GRP-R KO mice were captured with a video camera attached to a light microscope. The areas of interest were outlined based on cellular morphology and c-Fos immunoreactive nuclei were counted using automated image analysis software. Counts were made at one level of the AP ( 7·48 mm bregma), three levels of the medial NTS (obex, 7·48 and 7·20 mm bregma) and in the PVN, as described in the atlas of Franklin & Paxinos (1997) . These brain regions were selected for evaluation because they exhibit increased c-Fos activation in response to i.p. injection of BN (Li & Rowland 1996) and participate in the control of food intake in rats.
c-Fos activation in response to i.p. injection of saline in a combined control group consisting of GRP-R KO (n=3) and WT (n=2) mice was compared with the response produced by 32 nmol/kg BN in GRP-R KO (n=5) and WT (n=5) mice using separate ANOVAs at each brain site.
Body weight
To determine if differences in body weight gain were present between WT and GRP-R KO mice, monthly body weights over a period of 25-54 months were obtained from animals backcrossed nine generations to C57BL/J6 mice (n=7 per group). Data were analyzed by ANOVA and analyses of simple effects were used to determine age-related differences between groups.
Receptor autoradiography
To verify that GRP-R deficient mice were devoid of functional GRP receptors, receptor autoradiography was performed on the fundal region of the stomach, an area that expresses high densities of GRP-R (Ladenheim et al. 1997) . To determine if NMB receptors remained intact, receptor autoradiography was also performed on the anterior olfactory nucleus, a brain region containing a high density of NMB-R (Wada et al. 1991 , Ladenheim et al. 1992 .
At the conclusion of the behavioral experiments, GRP-R KO (n=3) and WT mice (n=3) were anesthetized with Euthasol (Delmarva Labs) and the gastric fundus was removed and flash frozen in isopentane that had been cooled on dry ice. Twenty micrometer tissue sections were cut on a cryostat, thaw-mounted onto gelatin-coated slides and stored at -70 C until used for analysis of GRP-R binding.
Tissue sections were preincubated for 20 min at room temperature in 50 mM Mes buffer that contained 0·5% BSA (pH 6·5). They were then incubated at room temperature in 50 mM Mes buffer with the addition of 0·5% BSA, 130 mM NaCl, 7·7 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, 0·025% bacitracin, 4 mg/ml leupeptin, 2 mg/ml chymostatin and 40 pM [ 125 ]BN for 300 min. The sections were thoroughly washed (4 5 min) in ice-cold 50 mM Mes buffer containing 0·5% BSA and dried under a stream of warm air. They were then dessicated overnight and placed in an X-ray cassette with Hyperfilm-3H (Amersham) for 3 days.
Results
Receptor autoradiography
Binding of 125 I- [Tyr 4 ]BN in the gastric fundus is shown in Fig. 1A and B. There was a high density of binding exhibited in the circular muscle layer in WT mice (Fig.  1A) . In contrast, binding of [ 125 ]BN was absent in this region in GRP-R KO mice (Fig. 1B) .
In the anterior olfactory nucleus, the density of BN binding sites was comparable in both WT (Fig. 1C) and GRP-R KO mice (Fig. 1D) . Binding sites in this brain region have previously been characterized as NMB-R (Wada et al. 1990 , 1991 , Ladenheim et al. 1992 ) and thus should be unaffected. However, 125 I- [Tyr 4 ]BN binding in the cortex was reduced in GRP-R KO compared with WT mice because this region contains a mixture of GRP-Rs and NMB-Rs (Wada et al. 1990 , Ladenheim et al. 1992 (Fig. 1D ).
Behavioral testing with peptides
The effects of BN, GRP 18-27 , NMB and CCK on suppression of glucose intake in GRP-R KO and WT mice are shown in Figs 2-5. After i.p. administration of BN (Fig. 2) , WT mice significantly suppressed glucose intake at 15 min ( Fig. 2A, F(5,20) =7·073, P<0·001) and 30 min (Fig. 2B, F(5,20)=4·371, P=0·011) . The comparison of individual doses revealed that BN-induced suppression of glucose intake occurred with 10 and 32 nmol/kg at 15 min and with 3·2, 10 and 32 nmol/kg at 30 min (P<0·05). In contrast, GRP-R KO mice failed to suppress glucose intake at any dose at either time point (P>0·05).
In response to i.p. administration of GRP [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] (Fig. 3) , WT mice exhibited a significant dose-dependent reduction of glucose intake at both 15 min (Fig. 3A, F(5,20) = 4·20, P=0·01) and 30 min (Fig. 3B, F(5,20) =0·3287, P<0·03). The suppression of glucose intake was significant at the 32, 100 and 320 nmol/kg dosages at both 15 and 30 min. As seen with BN, the GRP-R KO mice did not suppress glucose at any dose tested (P>0·05).
When NMB was injected i.p., neither WT or GRP-R KO mice reduced glucose intake at any dose tested at either 15 min (Fig. 4A ) or 30 min (Fig. 4B ) post-injection (P>0·05).
Administration of the non-BN-related peptide, CCK (Fig. 5) , produced a significant dose effect at 15 min (Fig. 5A ) in both GRP-R KO mice (F(4,16)=19·67, P<0·0001) and WT mice (F(5,20)=35·1, P<0·0001). Planned t comparisons indicated that GRP-R KO mice significantly suppressed intake at the 1, 3·2 and 10 nmol/kg doses, whereas a significant suppression was not seen until the 3·2 nmol/kg dose in WT mice.
At 30 min (Fig. 5B) , a significant dose effect and a significant group-dose interaction were evident (F(4,36)=3·516, P=0·016), indicating that the degree of suppression was greater in the GRP-R KO than WT mice at high doses of CCK.
Meal pattern analysis
Results from the 24 h analysis of feeding patterns in WT and GRP-R KO mice are shown in Table 1 . The total amount of food consumed (total grams and total number of pellets) within this time period was not significantly different between groups (P>0·05). Meal size (number of pellets and grams consumed) was significantly greater in GRP-R KO mice compared with WT mice (P<0·05). While there was a trend towards a decreased number of meals consumed within 24 h this did not reach statistical significance.
c-Fos immunohistochemistry
Quantification of c-Fos immunoreactive cells following i.p. administration of saline or 32 nmol/kg BN in WT and GRP-R KO mice is shown in Fig. 6 . This dose of BN elicited a significant increase in c-Fos activation in WT mice in all brain regions evaluated (P<0·05). Significant elevations in BN-induced c-Fos immunoreactivity in GRP-R KO mice were detected only in the PVN, however the degree of activation was significantly less compared with WT mice (P<0·05).
Body weight
The body weights of GRP-R KO and WT control mice over a period of 25-54 weeks are shown in Fig. 7 . GRP-R KO body weights were significantly greater than WT beginning at week 45 (P<0·01).
Discussion
In an earlier study, we demonstrated that mice with a targeted deletion of the GRP-R exhibited several differences compared with their WT littermates. Although measures of embryonic mortality, reproductive abnormalities and organ pathology were similar to WT littermates, GRP-R KO mice displayed a lack of [ 125 ]BN binding to mouse acinar cells, a loss of BN-induced amylase release from dispersed pancreatic acinar cells and a deficit BN-induced suppression of food intake (Hampton et al. 1998) .
Based on the binding characteristics of BN, our initial interpretation from our previous study was that GRP-R was solely responsible for the feeding effects of BN. However, because experiments examining the contribution of individual BN receptor subtypes to feeding suppression by BN in rats have often been difficult to reconcile it was also necessary to evaluate the feeding effects of GRP and NMB in GRP-R KO and WT mice to be completely confident in this interpretation.
Therefore, in the present study we fully characterized the feeding response to BN-like peptides in GRP-R KO mice, as well as examined the contribution of GRP-R to body weight and normal controls of food intake. The finding that BN failed to reduce food intake in GRP-R KO mice replicates the results of our earlier study (Hampton et al. 1998) . In the present study, the inability of GRP to suppress glucose intake in GRP-R KO mice and lack of effect of NMB in both GRP-R KO and WT mice is consistent with the conclusion that the feeding effects of BN-like peptides are mediated entirely by the GRP-R in mice.
Although a previous study using WT and NMB-R deficient mice (Ohki-Hamazaki et al. 1999 ) reported a similar conclusion, their study was based on examining feeding suppression using only a single threshold dose of NMB at a time when the majority of the feeding effects of NMB have diminished. Therefore to completely rule out the possibility that NMB does not contribute to feeding suppression in mice it was necessary to perform a complete dose-response analysis in both GRP-R KO and WT mice as well as evaluate earlier time points.
The inability of NMB to reduce food intake in mice is in contrast to our earlier report examining BN receptor contribution to feeding suppression in rats. Several experimental results have supported the view that NMB suppresses food intake independent of an interaction with GRP receptors in rats. For example, comparisons of the dose-effect curves for BN, GRP and NMB have indicated that, even at high dosages, NMB was less potent than either BN or GRP in reducing food intake. Furthermore, when a dose of NMB that was maximal for suppressing food intake was combined with a submaximal dose of GRP, the resulting suppression was greater than when either peptide was given alone (Ladenheim et al. 1996b) . Finally, studies using a selective NMB-R antagonist demonstrated a complete blockade of feeding suppression induced by NMB but no effect on suppression induced by GRP (Ladenheim et al. 1994) . These data suggest that species differences exist in the contribution of specific BN receptor subtypes to reduce food intake. The analysis of c-Fos activation in response to BN administration in GRP-R KO and WT mice was in agreement with behavioral results. While BN resulted in increased c-Fos-positive cells in the AP, NTS and PVN in WT mice, only the PVN exhibited a significant increase in GRP-R KO mice. Previous studies have demonstrated that the caudal hindbrain, particularly the NTS, is a critical site for the suppression of food intake produced by peripherally administered BN-like peptides (Ladenheim & Ritter 1993) . Because BN activates both GRP-R and NMB-R, the inability of BN to elicit c-Fos activation in the NTS in GRP-R KO mice supports the interpretation that the GRP-R is the necessary receptor subtype for the feeding response in mice. Increased c-Fos activation in the PVN mice presumably resulted from activation of both GRP-R and NMB-R, because c-Fos induction still occurred in GRP-R KO mice after BN administration but was decreased compared with WT mice. Despite the lack of feeding effect of NMB these results show that NMB is still biologically active in mice. However, activation of this neuronal population must not contribute to feeding suppression since neither BN nor NMB suppressed feeding in GRP-R KO mice.
GRP-R KO mice also exhibited increased sensitivity to exogenous administration of CCK, in that a lower dose was required to produce a significant feeding suppression and the magnitude of the effect was greater than that of WT mice. It is possible that differences in sensitivity of GRP-R KO mice to other factors that control food intake may serve to compensate for loss of BN receptor activity and regulate food intake. However, our finding that individual meals were larger in GRP-R KO mice suggests that in normal feeding situations the compensation by other factors that could reduce meal size is incomplete.
At the time of behavioral testing there were no differences in body weight observed between GRP-R KO and WT mice. Yamada et al. (2000) previously reported that cumulative 24 h food intake was not different between GRP-R KO mice and their WT littermates, leading to the conclusion that lack of GRP-R did not affect food consumption. However, by conducting a more detailed analysis of meal patterns we revealed that differences in food consumption do exist between GRP-R KO and WT mice.
Previous studies have indicated that vena caval infusions of GRP given at the onset of the first nocturnal meal in spontaneously feeding rats reduce meal size with no significant effect on intermeal interval (Rushing et al. 1998) . Therefore, our finding that GRP-R KO mice consume more at individual meals than WT mice is consistent with a deficit in a meal-related satiety signal. Furthermore, though not statistically significant due to a small sample size, the trend that less total meals were consumed to compensate for the increase in meal size suggests that there is a non-GRP-R-dependent compensatory mechanism that allows these mice to still regulate their overall energy intake.
Although no differences in body weight were evident during the behavioral testing period, the long-term comparison of body weight between the GRP-R KO and WT mice revealed a small (12%), but significant, age-related increase in body weight beginning when the animals reached 45 weeks of age. Because we only conducted meal pattern analysis at one age, we do not know if GRP-R KO mice develop a less efficient means to compensate for larger meal size as they get older. As well, GRP-R KO mice have been shown to exhibit decreased glucagon-like peptide 1 secretion, impairment of insulin release and abnormal glucose tolerance that could eventually lead to metabolic disturbances and obesity (Persson et al. 2000) . A determination of energy expenditure in GRP-R KO mice at different ages would be required to address this possibility.
In summary, the results of this study demonstrate that the satiety action of peripherally administered BN-like peptides is mediated by the GRP-R in mice. The increase in meal size seen in GRP-R KO mice suggests that this receptor subtype contributes to meal termination. GRP-R KO mice provide a useful approach for determining how BN receptor subtypes differentially affect behavioral and physiological responses to BN-like peptides.
